Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26FCM2A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,196
Award facts
- Contract value 100% obligated
- $52,196.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $52,196.25 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (quantity: 90 units) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC vehicle supports global pharmaceutical procurement for military healthcare programs and enables the company to supply a comprehensive range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contracts demonstrating its capability to meet competitive procurement requirements across multiple therapeutic domains. The company's federal contract awards with DLA encompass brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities, with individual delivery orders ranging significantly in value. The delivery of Gemtesa, a medication used in the treatment of overactive bladder, reflects the company's role as a critical vendor in the federal medical supply chain supporting military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCM2A?
SPE2DR26FCM2A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FCM2A worth?
The government has obligated $52,196 on SPE2DR26FCM2A.
Is contract SPE2DR26FCM2A an order under another contract?
Yes. SPE2DR26FCM2A is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCM2A competed?
The extent of competition for SPE2DR26FCM2A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award